Whitehawk Therapeutics Inc (WHWK)

$1.45 -0.06 (-3.97%)
Market Cap 38.03M
Revenue (ttm) 25.98M
Net Income (ttm) -63.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -245.15%
Debt to Equity Ratio 0.00
Volume 54,900
Avg Vol 139,556
Day's Range N/A - N/A
Shares Out 24.70M
Stochastic %K 16%
Beta 0.75
Analysts Hold
Price Target $2.00

Latest News on WHWK

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 26, 2025, 8:00 AM EDT - 4 weeks ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:52 AM EDT - 5 weeks ago

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Mar 18, 2025, 4:00 PM EDT - 5 weeks ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company